The DOI matches its Crossref record, with a small difference in title or year; 25 of the 25 references it cites were found in a registry or an index.
Efficacy of treatments for anxiety disorders: a meta-analysis
Abstract
To our knowledge, no previous meta-analysis has attempted to compare the efficacy of pharmacological, psychological and combined treatments for the three main anxiety disorders (panic disorder, generalized anxiety disorder and social phobia). Pre-post and treated versus control effect sizes (ES) were calculated for all evaluable randomized-controlled studies (n = 234), involving 37,333 patients. Medications were associated with a significantly higher average pre-post ES [Cohen's d = 2.02 (1.90-2.15); 28,051 patients] than psychotherapies [1.22 (1.14-1.30); 6992 patients; P < 0.0001]. ES were 2.25 for serotonin-noradrenaline reuptake inhibitors (n = 23 study arms), 2.15 for benzodiazepines (n = 42), 2.09 for selective serotonin reuptake inhibitors (n = 62) and 1.83 for tricyclic antidepressants (n = 15). ES for psychotherapies were mindfulness therapies, 1.56 (n = 4); relaxation, 1.36 (n = 17); individual cognitive behavioural/exposure therapy (CBT), 1.30 (n = 93); group CBT, 1.22 (n = 18); psychodynamic therapy 1.17 (n = 5); therapies without face-to-face contact (e.g. Internet therapies), 1.11 (n = 34); eye movement desensitization reprocessing, 1.03 (n = 3); and interpersonal therapy 0.78 (n = 4). The ES was 2.12 (n = 16) for CBT/drug combinations. Exercise had an ES of 1.23 (n = 3). For control groups, ES were 1.29 for placebo pills (n = 111), 0.83 for psychological placebos (n = 16) and 0.20 for waitlists (n = 50). In direct comparisons with control groups, all investigated drugs, except for citalopram, opipramol and moclobemide, were significantly more effective than placebo. Individual CBT was more effective than waiting list, psychological placebo and pill placebo. When looking at the average pre-post ES, medications were more effective than psychotherapies. Pre-post ES for psychotherapies did not differ from pill placebos; this finding cannot be explained by heterogeneity, publication bias or allegiance effects. However, the decision on whether to choose psychotherapy, medications or a combination of the two should be left to the patient as drugs may have side effects, interactions and contraindications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This gap exists despite strong evidence of the efficacy of psychological and pharmacological interventions across the lifespan.[11][12][13][14][15][16][17]”
From The Classification of Anxiety and Fear-Related Disorders in the ICD-11: Review: Anxiety and Fear-Related Disorders in ICD-11 (2016) · cites this paper as [11]
In the citing paper
“Cognitive behavioral therapy (CBT) is an effective treatment for several anxiety disorders [19, 20].”
From Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial (2023) · cites this paper as [20]
In the citing paper
“Current treatments for generalized anxiety disorder (GAD) often yield suboptimal outcomes, partly because of insufficient targeting of underlying psychological mechanisms (eg, avoidance reinforcement learning).”
From Clinical Efficacy and Psychological Mechanisms of an App-Based Digital Therapeutic for Generalized Anxiety Disorder: Randomized Controlled Trial (2021) · cites this paper as [9]
In the citing paper
“Anxiety treatment has largely relied on antidepressant medications and psychotherapy (eg, CBT). These have yielded medium effect sizes for anxiety [9].”
From Clinical Efficacy and Psychological Mechanisms of an App-Based Digital Therapeutic for Generalized Anxiety Disorder: Randomized Controlled Trial (2021) · cites this paper as [9]
In the citing paper
“Psychological placebo effects were estimated on average 0.83 in patients with anxiety disorders87.”
From A systematic review and meta-analysis of acceptance- and mindfulness-based interventions for DSM-5 anxiety disorders (2021) · cites this paper as [87]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 1×
“To assess publication biases, ‘fail-safe Ns’ (number of negative studies needed to reject the hypothesis that a treatment differs from a control group), P values for Egger’s regression intercept (a method to quantify the bias captured by a funnel plot) for between-group effect sizes and effect sizes adjusted for publi…”
MethodThe assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455 · cited 6×
“When only PDA and GAD studies with a minimum HAMA baseline score of 22 were analysed separately, medications still showed significantly higher effect sizes (d= 2.52; confidence interval 2.35–2.69; n= 95) than psychotherapies (d= 1.71, 1.34–2.08; n= 15; P< 0.0005).”
MethodInfluentialThe size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282
Liebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Meta-analysis of experiments with matched groups or repeated measures designs
Dunlap, W. P., Cortina, J. M., Vaslow, J. B., & Burke, M. J. (1996) · Psychological Methods · doi:10.1037/1082-989x.1.2.170 · Cited by 1,693 · cited 1×
“However, as this correlation was not provided in any of the studies selected for the current analysis, Cohen’s d was calculated by subtracting the posttreatment mean from the pretreatment mean and dividing the difference by the pretreatment SD of the measure (Dunlap et al., 1996).”
MethodBaldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
Self-citationCuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2013) · World Psychiatry · doi:10.1002/wps.20038 · Cited by 540
Hróbjartsson, A., Thomsen, A. S. S., Emanuelsson, F., Tendal, B., Hilden, J., Boutron, I., Ravaud, P., & Brorson, S. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.120744 · Cited by 527 · cited 1×
“Moreover, blinding is difficult in psychotherapy studies, which may have affected effect sizes (Hrobjartsson et al., 2013).”
BackgroundHoge, E. A., Bui, E., Marques, L., Metcalf, C. A., Morris, L. K., Robinaugh, D. J., Worthington, J. J., Pollack, M. H., & Simon, N. M. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08083 · Cited by 511 · cited 1×
“In one available study for each comparison, PDTh, IPT and mindfulness therapy did not differ from a psychological placebo (Knijnik et al., 2004; Lipsitz et al., 2008; Hoge et al., 2013), whereas PDTh (Leichsenring et al.”
Result
Research works printed but not linked: 1
- Furukawa, 2007, Cochrane Database Syst Rev, 1, CD004364
Cited by
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079
Self-citationGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
“I ge e al, effe t sizes fo d ug t eat e t of a iet disorders appear to be greater than for psychological treatments (Bandelow et al., 2015).”
Andrews, G., Basu, A., Cuijpers, P., Craske, M. G., McEvoy, P., English, C. L., & Newby, J. M. (2018) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2018.01.001 · Cited by 922
The use of virtual reality technology in the treatment of anxiety and other psychiatric disorders
Maples-Keller, J. L., Bunnell, B. E., Kim, S.-J., & Rothbaum, B. O. (2017) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000138 · Cited by 862
“Anxiety Disorders Awide body of research has suggested large treatment effects for exposure-based therapy for anxiety disorders.(11) Modern exposure therapy is based on emotion-processing theory, which posits that fearmemories are structures that contain information regarding fear stimuli, responses, and meaning.”
BackgroundCarpenter, J. K., Andrews, L. A., Witcraft, S. M., Powers, M. B., Smits, J. A. J., & Hofmann, S. G. (2018) · Depression and Anxiety · doi:10.1002/da.22728 · Cited by 846
“vious meta-analyses comparing the effect of CBT to waitlist or other control treatments for disorder-specific symptoms (Bandelow et al., 2015), depression (Cuijpers et al.”
BackgroundMethodResultInfluential
Metadata
- Authors
- Bandelow, B., Reitt, M., Röver, C., Michaelis, S., Görlich, Y., & Wedekind, D.
- Affiliations
- University of Göttingen (DE)
- Corresponding author
- Bandelow, Borwin
- Venue
- International Clinical Psychopharmacology
- Published
- 2015-07
- Volume
- 30
- Issue
- 4
- Pages
- 183-192
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2072711370
- Cited by
- 555
- References
- 25
- Citations by year
- 2026: 44 · 2025: 57 · 2024: 66 · 2023: 50 · 2022: 55 · 2021: 55 · 2020: 51 · 2019: 44 · 2018: 52 · 2017: 35 · 2016: 37 · 2015: 8
- FWCI
- 66.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- GRO (submittedVersion)
- Funders
- AstraZeneca
- Servier
- H. Lundbeck A/S
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Keywords
- anxiety disorders, panic disorder, generalized anxiety disorder, social anxiety disorder, pharmacotherapy, psychotherapy, cognitive behavioral therapy, serotonin-norepinephrine reuptake inhibitors, benzodiazepines, selective serotonin reuptake inhibitors, tricyclic antidepressants, mindfulness therapy, relaxation training, online therapy, EMDR, interpersonal psychotherapy, psychodynamic psychotherapy, exercise therapy, placebo response
- MeSH terms
- Anxiety Disorders, Combined Modality Therapy, Humans, Phobic Disorders, Psychotherapy, Risk Factors, Anti-Anxiety Agents, Panic Disorder, Treatment Outcome, Patient Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of treatments for anxiety disorders: a meta-analysis. https://app.cochat.ai/papers/10.1097/yic.0000000000000078
- The paper
- Bandelow, B., Reitt, M., Röver, C., Michaelis, S., Görlich, Y., & Wedekind, D. (2015). Efficacy of treatments for anxiety disorders: a meta-analysis. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000078
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.